Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Solventum Corp
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
9.0% vs price
Base Case (Median)
62.8% vs price
Bull Case (75th pct.)
158.9% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $241.95 | 175.4% | High (40%) |
| PE Comparable | $183.90 | 109.3% | Medium (25%) |
| Growth Trajectory DCF | $308.78 | 251.5% | Medium (20%) |
| Graham Number | $73.40 | -16.4% | Medium (40%) |
| EV/EBITDA | $102.21 | 16.3% | Medium (20%) |
| Earnings Power Value | $93.59 | 6.5% | Medium (50%) |
Based on 6 out of 7 methods, SOLV appears undervalued at the current price of $87.85. The base case fair value of $143.05 implies 62.8% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.